Concepedia

Mark R. Tanner

MR

25

Publications

1K

Citations

18

H-Index

1987

Active since

Affiliations

Baylor College of Medicine(Current)

The University of Texas MD Anderson Cancer Center

Peptides International (United States)

Icahn School of Medicine at Mount Sinai

Monash University

Mark R. Tanner is an author at Baylor College of Medicine specializing in medicine, immunology, and hematology.

ORCID

Top concepts

Publications per year

1987–2024

25

Publications

25

AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9

Ang Li, Mark R. Tanner, Ciaran M. Lee et al. · Molecular Therapy · 2020 · 217 citations · Full text

Kv1.3 channel‐blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases

Sandeep Chhabra, Shih Chieh Chang, Hai M. Nguyen et al. · The FASEB Journal · 2014 · 88 citations · Full text

A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases

Harunur Rashid, Redwan Huq, Mark R. Tanner et al. · Scientific Reports · 2014 · 81 citations · Full text

Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog

Mark R. Tanner, Rajeev B. Tajhya, Redwan Huq et al. · Clinical Immunology · 2017 · 72 citations · Full text

, , +12

Blocking KV1.3 Channels Inhibits Th2 Lymphocyte Function and Treats a Rat Model of Asthma

Shyny Koshy, Redwan Huq, Mark R. Tanner et al. · Journal of Biological Chemistry · 2014 · 66 citations · Full text

Rows per page

1–5 of 25